{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-004714","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2025-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.222238+00:00","generated_at":"2026-05-27T22:25:32.358672+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Envoy Medical enters $15M at-the-market equity offering with Roth Capital","bullets":["ATM agreement with Roth Capital Partners for up to $15M of Class A common stock.","Sales agent compensation is 3.0% of gross proceeds; $50K expense cap.","Shares sold at market prices; no minimum obligation to sell.","Offering made under effective S-3 registration filed Oct 2024.","Company may suspend sales at any time; proceeds for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-004714","json":"https://secwatch.observer/filing/0001213900-25-004714.json","markdown":"https://secwatch.observer/filing/0001213900-25-004714.md","text":"https://secwatch.observer/filing/0001213900-25-004714.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025004714/0001213900-25-004714-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025004714/ea0228064-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T22:25:32.358672+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}